The recombinant ACE2 protein may be another potential therapeutic candidate to protect against ALI/ARDS patients, as indicated in patients with H5N1, H7N9, or SARS infections.17, 20, 21. This evidence concerns the gene ACE2 and acute respiratory distress syndrome.